Biosenta Statistics

Total Valuation

Biosenta has a market cap or net worth of CAD 4.74 million. The enterprise value is 10.87 million.

Market Cap	4.74M
Enterprise Value	10.87M

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Biosenta has 33.83 million shares outstanding. The number of shares has increased by 13.33% in one year.

Current Share Class	33.83M
Shares Outstanding	33.83M
Shares Change (YoY)	+13.33%
Shares Change (QoQ)	+1.51%
Owned by Insiders (%)	26.07%
Owned by Institutions (%)	6.47%
Float	18.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,657.91
PB Ratio	-0.53
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.30
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.31

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-10.91
Interest Coverage	-1.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-525.29%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	39.12%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	0.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.85% in the last 52 weeks. The beta is 0.03, so Biosenta's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-65.85%
50-Day Moving Average	0.13
200-Day Moving Average	0.14
Relative Strength Index (RSI)	55.81
Average Volume (20 Days)	1,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biosenta had revenue of CAD 1,782 and -2.53 million in losses. Loss per share was -0.08.

Revenue	1,782
Gross Profit	1,088
Operating Income	-1.26M
Pretax Income	-2.53M
Net Income	-2.53M
EBITDA	-1.26M
EBIT	-1.26M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 4,215 in cash and 6.14 million in debt, giving a net cash position of -6.14 million or -0.18 per share.

Cash & Cash Equivalents	4,215
Total Debt	6.14M
Net Cash	-6.14M
Net Cash Per Share	-0.18
Equity (Book Value)	-8.95M
Book Value Per Share	-0.27
Working Capital	-3.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -537,161 and capital expenditures -25,861, giving a free cash flow of -563,022.

Operating Cash Flow	-537,161
Capital Expenditures	-25,861
Free Cash Flow	-563,022
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	61.05%
Operating Margin	-70,896.46%
Pretax Margin	-141,906.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biosenta does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.33%
Shareholder Yield	n/a
Earnings Yield	-53.39%
FCF Yield	-11.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.

Last Split Date	Jun 28, 2016
Split Type	Reverse
Split Ratio	0.0666666666

Scores

Biosenta has an Altman Z-Score of -338.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-338.23
Piotroski F-Score	3